Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4DJH

Structure of the human kappa opioid receptor in complex with JDTic

4DJH の概要
エントリーDOI10.2210/pdb4djh/pdb
分子名称Kappa-type opioid receptor, Lysozyme, (3R)-7-hydroxy-N-{(2S)-1-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]-3-methylbutan-2-yl}-1,2,3,4-tetrahydroisoquinoline-3-carboxamide, CITRIC ACID, ... (6 entities in total)
機能のキーワードjdtic, gpcr newtork, psi-biology, kor, hkor, kop, structural genomics, protein structure initiative, gpcr network, g-protein coupled receptor, gpcr, 7tm, kappa opioid receptor, dynorphin, membrane protein, transmembrane, hormone receptor, hydrolase, hormone receptor-antagonist complex, hormone receptor/antagonist
由来する生物種Homo Sapiens (human, Bacteriophage T4)
詳細
細胞内の位置Cell membrane ; Multi-pass membrane protein : P41145
タンパク質・核酸の鎖数2
化学式量合計110629.66
構造登録者
主引用文献Wu, H.,Wacker, D.,Mileni, M.,Katritch, V.,Han, G.W.,Vardy, E.,Liu, W.,Thompson, A.A.,Huang, X.P.,Carroll, F.I.,Mascarella, S.W.,Westkaemper, R.B.,Mosier, P.D.,Roth, B.L.,Cherezov, V.,Stevens, R.C.
tructure of the human kappa-opioid receptor in complex with JDTic
Nature, 485:327-332, 2012
Cited by
PubMed Abstract: Opioid receptors mediate the actions of endogenous and exogenous opioids on many physiological processes, including the regulation of pain, respiratory drive, mood, and--in the case of κ-opioid receptor (κ-OR)--dysphoria and psychotomimesis. Here we report the crystal structure of the human κ-OR in complex with the selective antagonist JDTic, arranged in parallel dimers, at 2.9 Å resolution. The structure reveals important features of the ligand-binding pocket that contribute to the high affinity and subtype selectivity of JDTic for the human κ-OR. Modelling of other important κ-OR-selective ligands, including the morphinan-derived antagonists norbinaltorphimine and 5'-guanidinonaltrindole, and the diterpene agonist salvinorin A analogue RB-64, reveals both common and distinct features for binding these diverse chemotypes. Analysis of site-directed mutagenesis and ligand structure-activity relationships confirms the interactions observed in the crystal structure, thereby providing a molecular explanation for κ-OR subtype selectivity, and essential insights for the design of compounds with new pharmacological properties targeting the human κ-OR.
PubMed: 22437504
DOI: 10.1038/nature10939
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.9 Å)
構造検証レポート
Validation report summary of 4djh
検証レポート(詳細版)ダウンロードをダウンロード

252456

件を2026-04-22に公開中

PDB statisticsPDBj update infoContact PDBjnumon